Drug Development | Global Biodefense

Menu

Latest stories

BARDA Exercises First Option in Transition from BioThrax to AV7909 Anthrax Vaccine

Illustrative representation of MRSA - Antibiotic Resistance

In Fight Against Superbugs, BARDA Looks to Shore Up National Stockpile Countermeasures

More on pathogens and preparedness

CBD S&T Conference 2019 – Chemical and Biological Defense

by Global Biodefense November 18, 2019, 12:00 am
BARDA Industry Day 2019

by Global Biodefense October 15, 2019, 12:00 am
USAID Seeks Innovations in Malaria Vaccine Development
BARDA Extends Strategic Partnership with JLABS

by Global Biodefense April 14, 2019, 7:03 pm
Superbugs & Superdrugs 2019

by Global Biodefense March 18, 2019, 12:00 am
NICBR Winter Symposium on Novel Therapeutics

by Global Biodefense January 24, 2019, 12:00 am
New Vaccine Manufacturing Innovation Centre Bolsters UK Pandemic Preparedness
BARDA Looks to Expand Clinical Studies Network for Biodefense Countermeasures

by Global Biodefense January 14, 2019, 8:00 am
Innovations in Regulatory Science Summit

by Global Biodefense January 5, 2019, 8:00 am
FDA Public Webinar: Genome Editing in Animals

by Global Biodefense December 3, 2018, 12:00 am
Superbugs & Superdrugs USA

Back to Top